COST-EFFECTIVENESS ANALYSIS OF DUPILUMAB FOR THE TREATMENT OF PRURIGO NODULARIS IN ADULT PATIENTS IN ITALY

被引：0
|
作者：
Prada, M. [1 ]
Fagnocchi, G. [2 ]
Aiello, A. [1 ]
Bertozzi, C. [1 ]
Ronci, G. [3 ]
Cassini, B. [3 ]
Pedone, M. P. [3 ]
机构：
[1] Intexo SB, Rome, RM, Italy
[2] Intexo SB, Milan, MI, Italy
[3] Sanofi SpA, Milan, Italy
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE276
引用
收藏
页码：S104 / S104
页数：1
相关论文
共 50 条
  • [21] Reduced Itch Associated With Dupilumab Treatment in 4 Patients With Prurigo Nodularis
    Mollanazar, Nicholas K.
    Elgash, May
    Weaver, Leslie
    Valdes-Rodriguez, Rodrigo
    Hsu, Sylvia
    JAMA DERMATOLOGY, 2019, 155 (01) : 121 - 122
  • [22] Dupilumab as promising treatment for prurigo nodularis: current evidences
    Toffoli, Ludovica
    Farinazzo, Eleonora
    Zelin, Enrico
    Agozzino, Marina
    Dianzani, Caterina
    Di Meo, Nicola
    Nan, Katiuscia
    Zalaudek, Iris
    Conforti, Claudio
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (03) : 1306 - 1311
  • [23] Dupilumab: A Safe and Successful Treatment in Refractory Prurigo Nodularis
    Cunha, Ines Machado
    Valadao, Ivone
    Gomes, Eva
    Marinho, Antonio
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (05): : 1365 - 1366
  • [24] Effective Treatment of Prurigo Nodularis with Dupilumab: A Case Report
    Liu, Chuan
    Xiong, J-Xia
    Chen, A-Jun
    Wang, Ping
    INDIAN JOURNAL OF DERMATOLOGY, 2022, 67 (05)
  • [25] Dupilumab for Treatment of Prurigo Nodularis: Real-Life Effectiveness for up to 84 Weeks
    Paganini, Claudia
    Talamonti, Marina
    Maffei, Virginia
    Di Raimondo, Cosimo
    Bianchi, Luca
    Galluzzo, Marco
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (03)
  • [26] Effectiveness and Safety of Dupilumab for Prurigo Nodularis in China: A Multicentric and Observational Study
    Zhao, Zuotao
    Song, Xiaoting
    Shang, Yuanyuan
    Liu, Lijuan
    Zheng, Rui
    Xia, Jianxin
    Liu, Qiang
    Hao, Guodong
    Li, Jie
    Geng, Songmei
    An, Jingang
    Wang, Qiang
    Liu, Xiaoyan
    Tang, Jianping
    Xiao, Yizhu
    Zhang, Litao
    ALLERGY, 2025,
  • [27] Dupilumab effectiveness in a case of prurigo nodularis and severe recalcitrant hidradenitis suppurativa
    Caro, Raffaele D. Caposiena
    Bazzacco, Giulia
    Zelin, Enrico
    Mazzoletti, Vanessa
    Agozzino, Marina
    Signoretto, Diego
    Di Meo, Nicola
    Zalaudek, Iris
    ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2024, 159 (03) : 370 - 371
  • [28] Ustekinumab plus dupilumab in the treatment of concomitant psoriasis and prurigo nodularis
    Kabbani, M.
    Mboyo Mpita, G.
    Benhadou, Farida
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (12) : E1050 - E1051
  • [29] Resolution of Treatment-Refractory Prurigo Nodularis With Dupilumab: A Case Series
    Wieser, Jill K.
    Mercurio, Mary Gail
    Somers, Kathryn
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (06)
  • [30] Effectiveness of Dupilumab in Pediatric Patient With Prurigo Nodularis-Like Atopic Dermatitis
    Yu, Yiling
    Ali, Kamran
    Da, Jiayang
    Qiu Yunmi
    Kai Gao
    Shan, JinPeng
    Xie, Tianci
    Min, Chen
    Li, Menghua
    Wu, Liming
    DERMATITIS, 2023, 34 (02) : 162 - +
12345